CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Ordinary shares	Additional paid-in capital	Accumulated other comprehensive loss	Retained earnings (accumulated deficit)
Beginning balance (in shares) at Dec. 31, 2022		105,049,411
Beginning balance at Dec. 31, 2022	$ 441,170		$ 1,222,063	$ (2,433)	$ (778,460)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation to employees	39,084		39,084
Exercise of options and vested RSUs (in shares)		1,137,751
Exercise of options and vested RSUs	5,211		5,211
Other comprehensive income (loss), net of tax benefit of $0	(258)			(258)
Net income (loss)	(53,061)				(53,061)
Ending balance (in shares) at Mar. 31, 2023		106,187,162
Ending balance at Mar. 31, 2023	432,146		1,266,358	(2,691)	(831,521)
Beginning balance (in shares) at Dec. 31, 2022		105,049,411
Beginning balance at Dec. 31, 2022	441,170		1,222,063	(2,433)	(778,460)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(207,043)
Ending balance (in shares) at Dec. 31, 2023		107,075,754
Ending balance at Dec. 31, 2023	362,496		1,353,468	(5,469)	(985,503)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation to employees	34,084		34,084
Exercise of options and vested RSUs (in shares)		528,020
Exercise of options and vested RSUs	213		213
Other comprehensive income (loss), net of tax benefit of $0	1,322			1,322
Net income (loss)	(38,760)				(38,760)
Ending balance (in shares) at Mar. 31, 2024		107,603,774
Ending balance at Mar. 31, 2024	$ 359,355		$ 1,387,765	$ (4,147)	$ (1,024,263)